Suchergebnisse - (Subject:"ritonavir")

PubPharm (98)

11

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks : results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

enthalten in: HIV clinical trials | 2016

von Overton, E. | Tebas, P. | Coate, B. | +5

12

Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

enthalten in: HIV clinical trials | 2016

von Calza, L. | Danese, I. | Magistrelli, E. | +6

13

Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection : the REMAIN Study

enthalten in: HIV clinical trials | 2016

von Teófilo, E. | Rocha-Pereira, N. | Kuhlmann, B. | +69

14

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

enthalten in: HIV clinical trials | 2015

von Young, B. | Squires, K. | Tashima, K. | +6

CommentOn: HIV Clin Trials. 2012 Sep-Oct;13(5):233-44. - PMID 23134624

15

Regimen selection in the OPTIONS trial of HIV salvage therapy : drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity

enthalten in: HIV clinical trials | 2015

von Tashima, K. | Mollan, K. | Na, L. | +8

16

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients

enthalten in: HIV clinical trials | 2014

von Kulkarni, R. | Abram, M. | McColl, D. | +6

17

Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients : a multicenter clinical experience

enthalten in: HIV clinical trials | 2014

von Gazzola, L. | Cicconi, P. | Ripamonti, D. | +6

18

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection : data from the ICONA foundation cohort

enthalten in: HIV clinical trials | 2014

von Di Biagio, A. | Nicolini, L. | Lorenzini, P. | +10

19

Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials

enthalten in: HIV clinical trials | 2014

von Powderly, W. | Hill, A. | Moecklinghoff, C.

20

Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone

enthalten in: HIV clinical trials | 2014

von Wang, Q. | Young, J. | Bernasconi, E. | +60